U.S. markets open in 1 hour

Nutra Pharma Corp. (NPHC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0098+0.0005 (+5.38%)
At close: 3:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0093
Open0.0090
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0090 - 0.0110
52 Week Range0.0010 - 0.0158
Volume20,682,341
Avg. Volume46,449,119
Market Cap63.753M
Beta (5Y Monthly)3.22
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications
    Newsfile

    Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications

    Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation Plantation, Florida--(Newsfile Corp. - February 23, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is providing updates today on their work ...

  • Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys
    Newsfile

    Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys

    Plantation, Florida--(Newsfile Corp. - February 12, 2021) - Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that they are focusing on their intellectual property portfolio and have engaged their IP attorneys at Christopher & Weisberg P.A."Intellectual property, including patents and trademarks, ...

  • Nutra Pharma Letter to Shareholders
    Newsfile

    Nutra Pharma Letter to Shareholders

    Plantation, Florida--(Newsfile Corp. - January 12, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has published a Letter to Shareholders on the Company's website."The last year was a challenging ...